NEW YORK (GenomeWeb) – Natera reported after the close of the market Thursday that its second quarter revenues jumped 15 percent year over year as its test volume rose sharply.

The San Carlos, California-based molecular diagnostics firm reported total revenues of $52 million, up from $45.1 million for Q2 2015 and besting the consensus Wall Street estimate of $50.6 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.